Skip to Main Content

Paper Details

Global chemical effects of the microbiome include new bile-acid conjugations.
Nature
261
2020
amino acid, bile acids, bile-acid, bile-acid synthesis genes, cystic fibrosis, farnesoid, farnesoid X receptor, gut diseases, human, humans, inflammatory bowel disease, leucocholic acid, metazoans, mice, microbiome dysbiosis, patients, phenylalanocholic acid, tyrosocholic acid
Author NameAffiliation
Pedro Belda-FerreUniversity of California San Diego
Michael DownesSalk Institute for Biological Studies
Michael DownesSalk Institute for Biological Studies
Ryan D WelchSalk Institute for Biological Studies
Gregory HumphreyUniversity of California San Diego
Clary B ClishBroad Institute of MIT and Harvard
Clary B ClishBroad Institute of MIT and Harvard
Mingxun WangSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Orit PoulsenUniversity of California San Diego
Brigid S BolandUniversity of California San Diego
Brigid S BolandUniversity of California San Diego
John T ChangUniversity of California San Diego
John T ChangUniversity of California San Diego
William J SandbornUniversity of California San Diego
Neha GargGeorgia Institute of Technology
Neha Garg
Ramnik J XavierBroad Institute of MIT and Harvard
Ramnik J XavierBroad Institute of MIT and Harvard
Gabriel G HaddadUniversity of California San Diego
Gabriel G HaddadUniversity of California San Diego
Curtis HuttenhowerBroad Institute of MIT and Harvard
Curtis HuttenhowerHarvard T. H. Chan School of Public Health
Ronald M EvansSalk Institute for Biological Studies
Ronald M EvansHoward Hughes Medical Institute, The Salk Institute for Biological Studies
Victor NizetSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Victor NizetUniversity of California San Diego
Victor Nizetuniversity of california san diego Center for Microbiome Innovation, University of California San Diego
Rob KnightUniversity of California San Diego
Rob Knightuniversity of california san diego Center for Microbiome Innovation, University of California San Diego
Rob KnightUniversity of California San Diego
Rob KnightUniversity of California San Diego
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Pieter C DorresteinUniversity of California San Diego
Pieter C Dorresteinuniversity of california san diego Center for Microbiome Innovation, University of California San Diego
  • 1 - 34

Datasets